The Alzheimer’s Disease Sequencing Project (ADSP) Functional Genomics Consortium (FunGen-AD) aims to apply cutting-edge genomics technologies and high-throughput genetic screening to understand the functional impacts underlying the genetic basis of susceptibility and resilience of Alzheimer’s Disease, and to identify genetics-guided targets for the prevention, diagnosis, and treatment of Alzheimer’s disease and related dementias (AD/ADRD).
Associated Groups
The FunGen Trainee Network aims to support trainee career development by fostering a collaborative community across computational and experimental research in functional genomics. The Network will provide a structured forum for trainees to present and discuss their research, gain exposure to diverse scientific approaches, and develop skills in scientific communication. Through regular meetings and ongoing interaction via a shared communication platform, the Network promotes peer mentoring, knowledge exchange, and professional growth, strengthening trainees’ career readiness and connections within the broader research community.
The FunGen xQTL Project provides comprehensive molecular quantitative trait loci (xQTL) analyses across multiple molecular phenotypes, along with integrative analysis for neurodegenerative disorders, particularly Alzheimer’s disease.
The FunGen-AD Consortium MPIs meet to discuss administrative topics for the Consortium.
The ADSP Functional Genomics Consortium (FunGen-AD) aims to apply cutting-edge genomics technologies and high-throughput genetic screening to understand the functional impacts underlying the genetic basis of susceptibility and resilience of Alzheimer’s disease, and to identify genetics-guided targets for the prevention, diagnosis, and treatment of Alzheimer’s disease and related dementias (AD/ADRD). The work group meets to discuss FunGen-AD projects and other administrative items.